Cogent Biosciences Inc (NASDAQ:COGT)
| 6.68 Delayed Data As of 4:00pm ET |  -0.11 / -1.62%Today’s Change | 5.83 Today|||52-Week Range 11.06 | -22.14% Year-to-Date |
Latest COGT News | Press Releases
No recent news for Cogent Biosciences Inc.
Today’s Trading
| Previous close | 6.79 |
| Today’s open | 6.67 |
| Day’s range | 6.55 - 6.81 |
| Volume | 1,836 |
| Average volume (3 months) | 253,149 |
| Market cap | $304.9M |
Data as of 4:00pm ET, 01/28/2022
Growth & Valuation
| Earnings growth (last year) | -287.13% |
| Earnings growth (this year) | +89.38% |
| Earnings growth (next 5 years) | +5.00% |
| Revenue growth (last year) | -65.02% |
| P/E ratio | NM |
| Price/Sales | 15.81 |
| Price/Book | 2.00 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AUTLAutolus Therapeutics... | -0.01 | -0.27% |
| ADMAADMA Biologics Inc | +0.03 | +2.21% |
| KMDAKamada Ltd | +0.03 | +0.51% |
| CGENCompugen Ltd | +0.05 | +1.51% |
Data as of 4:00pm ET, 01/28/2022
Financials
| Next reporting date | March 31, 2022 |
| EPS forecast (this quarter) | -$0.46 |
| Annual revenue (last year) | $7.9M |
| Annual profit (last year) | -$74.8M |
| Net profit margin | -950.43% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
